Form 4: Zimmer Biomet Executive Chad F. Phipps Reports Acquisition of Restricted Stock Units

Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc., reports the acquisition of 7,875 restricted stock units on February 25, 2025, vesting annually over three years.

Summary

• On February 25, 2025, Chad F. Phipps, Sr. VP/Gen Counsel/Secretary of Zimmer Biomet Holdings, Inc. acquired 7,875 restricted stock units.
• These restricted stock units represent a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock each.
• The restricted stock units vest annually over three years, starting on February 25, 2026.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns the executive's interests with the company's long-term performance.

Future Outlook

The restricted stock units will vest annually over three years, commencing February 25, 2026, suggesting a long-term incentive for the executive.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, common in publicly traded companies to ensure transparency and prevent insider trading. It reflects part of the executive compensation strategy at Zimmer Biomet.

Stakeholder Impact

• The acquisition of restricted stock units aligns the executive's interests with those of the shareholders, incentivizing long-term value creation.

Key Dates